Briefing Information for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee

FDA 

Disclaimer

Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).

FDA Briefing Material [PDF]

Xanodyne Pharmaceuticals, Inc. & Qualitest/Vintage Pharmaceuticals

Disclaimer

The statements contained in this document(s) are those of the product's sponsors, not FDA, and FDA does not necessarily agree with the sponsors’ statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Briefing Material [PDF]